Delivery Order SPE2DB22D3009-SPE2DB25FAS07
Award Date
2/24/25
Potential Completion Date
2/25/25
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ondansetron HCL 4 mg tablets. The $2,266.29 firm fixed-price contract has a completion date of May 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,277.07, is for the delivery of 4,564,792,273 units of the medication Ondansetron HCL 4 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of June 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,189.09, is for the delivery of Ondansetron HCL 4 mg tablets. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 23, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,506.19 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCL tablets. The contract has an ultimate completion date of February 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,200.98 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCL tablets to support military healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,835.52, is for the delivery of 4,566,151,241 units of Ondansetron HCL 4 mg Tablets by October 21, 2024. This is a delivery order contract with a firm fixed-price pricing type. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,077.14 firm fixed-price delivery order is for the supply of 4 mg Ondansetron HCL tablets to support military healthcare programs. The contract has a November 2024 completion date and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,137.76 Firm Fixed Price Delivery Order covers the supply of 4 mg Ondansetron HCL tablets in 500-count bottles. The contract has an ultimate completion date of January 14, 2025 and was awarded on January 13, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,614.43 firm fixed-price delivery order is for the supply of Ondansetron ODT 8 mg tablets. The contract has a period of performance through January 22, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,589.30, is for the delivery of Ondansetron ODT 4 mg tablets to support military healthcare programs. The contract is a delivery order with a firm fixed price pricing type and has a completion date of January 31, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...